Strikingly, the combination of IFNγ with subsequent administration of chemotherapy (PAC) led to limited metastatic disease (micrometastases) in vivo compared to the diffuse infiltration of the liver by metastatic tumors in the case of control and monotherapy with either IFNγ or PAC. This evidence concerns the gene IFNG and metastatic neoplasm.